These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4732262)

  • 1. [Comparison of the effect of various antiarrhythmic drugs on the model of experimental epinephrine arrhythmia].
    Vrbovský L
    Bratisl Lek Listy; 1973 Aug; 60(2):161-74. PubMed ID: 4732262
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiarrhythmic effect of the diethylaminoethylamide of dehydroabietic acid (substance E-25), quinidine and procaine amide in arrhythmia in anesthetized dogs, induced by K-strophanthin].
    Vrbovský L
    Bratisl Lek Listy; 1971; 56(2):161-79. PubMed ID: 5156932
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
    Igarashi T; Hashimoto N
    Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiarrhythmic activity of beta-aminoketones in comparison with quinidine and procaine amide in arrhythmia produced by calcium chloride in mice].
    Iur'ev EG; Iur'eva TI
    Farmakol Toksikol; 1973; 36(1):29-32. PubMed ID: 4685151
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the effects of disopyramide, dihydroquinidine and procainamide on 2 types of ventricular arrhythmias].
    Cosnier D; Grimal J; Duchene-Marullaz P
    Therapie; 1971; 26(1):97-107. PubMed ID: 5554772
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on models used for the evaluation of antiarrhythmic drugs.
    Baum T; Eckfeld DK; Shropshire AT; Rowles G; Varner LL
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):149-70. PubMed ID: 5111320
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the effects of various betaadrenergic blocking agents with known antiarrhythmic drugs on aconitine-arrhythmia produced by the cup method.
    Nakayama K; Oshima T; Kumakura S; Hashimoto K
    Eur J Pharmacol; 1971; 14(1):9-18. PubMed ID: 4396662
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 10. [Brevikarin dihydrochloride--a new original anti-arrhythmia agent].
    Denisenko PP; Vinogradova TV; Semenov AA
    Farmakol Toksikol; 1988; 51(2):50-3. PubMed ID: 3378605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiarrhythimic properties of ethmozine].
    Kaverina NV; Senova ZP; Vikxliàev IuI; Ul'iànova OV
    Farmakol Toksikol; 1970; 33(6):693-7. PubMed ID: 4103389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiarrhythmic drugs].
    Szekeres L
    Orv Hetil; 1970 Mar; 111(13):723-31. PubMed ID: 4908690
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-arrhythmia properties of pyromecaine].
    Zakusov VV; Prianishnikova NT; Cherniakova IV; Samvelian VM; L'vov MV
    Farmakol Toksikol; 1983; 46(5):32-7. PubMed ID: 6628657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmic properties of ethmosine (clinico-experimental study)].
    Kaverina NV; Senova ZP; Lyskovtsev VV
    Kardiologiia; 1978 Apr; 18(4):67-72. PubMed ID: 671970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actions and clinical use of the newer antiarrhythmic drugs.
    Hayes AH
    Ration Drug Ther; 1972 Jul; 6(7):1-6. PubMed ID: 5085124
    [No Abstract]   [Full Text] [Related]  

  • 19. The function of newer antiarrhythmic drugs under special consideration of beta blocking adrenergic agents.
    Shalsha KG
    Proc Rudolf Virchow Med Soc City N Y; 1968-1969; 27():201-11. PubMed ID: 4402617
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiarrhythmic drugs].
    Ben Naceur M; Houissa D
    Tunis Med; 1972; 50(4):305-13. PubMed ID: 4662464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.